OUTCOMES OF TREATMENT OF PEDIATRIC CHOROIDAL NEOVASCULARIZATION WITH INTRAVITREAL ANTIANGIOGENIC AGENTS

201431 citationsJournal Article

Authors

Igor Kozak · King Khaled Eye Specialist Hospital

Ahmad M. Mansour · American University of Beirut

Rocio I. Diaz · Retina Institute

Jorge I. Calzada · Retina Institute

Francesco Pichi · Ospedale San Giuseppe

Vanessa Cruz-Villegas · University of Puerto Rico System

M. Díaz-Llopis

Abstract

Intravitreal antiangiogenic therapy for choroidal neovascularization in pediatric patients seems temporarily safe and effective in majority of affected eyes. Because of the rarity and character of this condition, it is unlikely that any clinical trials will soon take place to study this or other treatment option.

Topics & Keywords

Retinopathy of Prematurity Studies Retinal Diseases and Treatments Retinal Development and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Retina

Volume 34, Issue 10, pp. 2044-2052

DOI: 10.1097/iae.0000000000000200

Field-Weighted Citation Impact: 2.14